EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Balancing act: The dual role of claudin‐2 in disease

Shanshan Wu, Jia Gao, Yiran Han, Wenzhe Zhang, Xue Li, Derun Kong, Hua Wang, Li Zuo

Annals of the New York Academy of Sciences · 2025

DOI: 10.1111/nyas.15311 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of the New York Academy of Sciences, 2025. Verfasst von Shanshan Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Claudin-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 151 Literaturangaben. Gefördert von: Natural Science Foundation of Anhui Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Claudin‐2 (CLDN2), a tight junction protein, is predominantly found in leaky epithelial cell layers where it plays a pivotal role in forming paracellular pores necessary for the efficient transport of cations and water. Its abundance is intricately regulated by upstream signals, modulating its synthesis, transport, and localization to adapt to diverse environmental changes. Aberrant expression levels of CLDN2 are observed in numerous pathological conditions including cancer, inflammation, immune disorders, fibrosis, and kidney and biliary stones. Recent advances have uncovered the mechanisms by which the loss or restoration of CLDN2 affects functions such as epithelial barrier, cell proliferation, renewal, migration, invasion, and tissue regeneration. This exerts a dual‐directional influence on the pathogenesis, perpetuation, and progression of diseases, indicating the potential to both accelerate and decelerate the course of disease evolution. Here, we discuss these nuanced bidirectional regulatory effects mediated by CLDN2, and how it may contribute to the progression or regression of disease when it becomes unbalanced.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Claudin-2HumansAnimalsTight JunctionsNeoplasmsInflammationClaudinsCell ProliferationEpithelial Cells

Stichwörter der Autor:innen

cancercell migrationcell proliferationclaudin‐2inflammationtight junction

Substanzen

Claudin-2CLDN2 protein, humanClaudins

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Innovation and Entrepreneurship Laboratory for College Students, Anhui Medical University, Hefei, China.
  • Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.
  • Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • The First College of Clinical Medicine, Anhui Medical University, Hefei, China.
  • Laboratory of Molecular Biology, Department of Biochemistry, School of Basic Medical Science, Anhui Medical University, Hefei, China.

Förderung

  • Natural Science Foundation of Anhui Province
  • National Natural Science Foundation of China

Zitieren

APA

Wu, S., Gao, J., Han, Y., Zhang, W., Li, X., Kong, D., Wang, H., & Zuo, L. (2025). Balancing act: The dual role of claudin‐2 in disease. Annals of the New York Academy of Sciences. https://doi.org/10.1111/nyas.15311

Vancouver

Wu S, Gao J, Han Y, Zhang W, Li X, Kong D, et al. Balancing act: The dual role of claudin‐2 in disease. Annals of the New York Academy of Sciences. 2025. doi:10.1111/nyas.15311

BibTeX
@article{Wu2025,
  author = {Wu, Shanshan and Gao, Jia and Han, Yiran and Zhang, Wenzhe and Li, Xue and Kong, Derun and Wang, Hua and Zuo, Li},
  title = {Balancing act: The dual role of claudin‐2 in disease},
  journal = {Annals of the New York Academy of Sciences},
  year = {2025},
  doi = {10.1111/nyas.15311}
}
Kostenlos starten →